EGFR mutations and ROS1 and ALK rearrangements in a large series of non‐small cell lung cancer in South India

BACKGROUND: Driver mutations are seen in 80% of lung adenocarcinomas, and they influence prognosis and choice of therapy. AIM: Aim of this study was to analyse the frequency of epidermal growth factor receptor (EGFR) mutations, ALK and ROS1 rearrangements and their association with age and gender in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarigopula, Anil, Ramasubban, Gayathri, Chandrashekar, Vani, Govindasami, Perumal, Chandran, Chitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941574/
https://www.ncbi.nlm.nih.gov/pubmed/32881404
http://dx.doi.org/10.1002/cnr2.1288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941574/
https://www.ncbi.nlm.nih.gov/pubmed/32881404
http://dx.doi.org/10.1002/cnr2.1288

Ejemplares similares